Overexpression of FASN and altered metabolism in prostate cancer cells are associated with inactivation of PTEN [28, 36, 37]; in contrast, PTEN expression is inversely correlated with FASN expression in prostate cancer [38], while inhibition of PTEN leads to the overexpression of FASN in vitro. Here, PTEN is linked to prostate carcinoma.